35 Recruiting Studies Using Folfox
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Folfox
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
📍 University of Florida — Gainesville, Florida
Pancreatic Adenocarcinoma
View Study & Checklist ➔Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
📍 University of Rochester, James P. Wilmot Cancer Center — Rochester, New York
Advanced Rectal Cancer
View Study & Checklist ➔Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
📍 Moffitt Cancer Center — Tampa, Florida
Rectal Adenocarcinoma
View Study & Checklist ➔Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
📍 Mayo Clinic - Arizona — Phoenix, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
📍 Research Site — Los Angeles, California
Metastatic Microsatellite-stable Colorectal Cancer
View Study & Checklist ➔A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Esophagogastric Cancer
View Study & Checklist ➔Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
📍 Stanford Cancer Center — Palo Alto, California
Neuroendocrine Tumors
View Study & Checklist ➔Organ Preservation in Early Rectal Cancer Patients
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
Rectal Cancer
View Study & Checklist ➔ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Dynamic Tumor Resistance
View Study & Checklist ➔Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
📍 Duke University Medical Center — Durham, North Carolina
Esophageal Adenocarcinoma
View Study & Checklist ➔A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
📍 University of Arizona Cancer Center — Tucson, Arizona
Colorectal Neoplasms
View Study & Checklist ➔Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)
📍 McGill University Health Centre — Montreal, Quebec
Colorectal Carcinoma
View Study & Checklist ➔A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
📍 Weill Cornell Medical College — New York, New York
Rectal Cancer
View Study & Checklist ➔Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.
📍 Allan Balir Cancer Center — Regina, Saskatchewan
Metastatic Colorectal Cancer
View Study & Checklist ➔A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
📍 MD Anderson Cancer Center — Houston, Texas
Solid Tumor, Adult
View Study & Checklist ➔A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
Solid Tumors
View Study & Checklist ➔Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
📍 Chao Family Comprehensive Cancer Center, University — Orange, California
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Gastric or Gastroesophageal Junction Adenocarcinoma
View Study & Checklist ➔alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
📍 Moffit Cancer Center — Tampa, Florida
Unresectable Metastatic Colorectal Cancer
View Study & Checklist ➔Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
📍 Mayo Clinic — Jacksonville, Florida
Unresectable Metastatic Colorectal Cancer
View Study & Checklist ➔MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
📍 Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin
Rectal Adenocarcinoma
View Study & Checklist ➔Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
📍 Research Site — Los Angeles, California
Gastric Cancer
View Study & Checklist ➔A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 Mayo Clinic Hospital — Phoenix, Arizona
Solid Tumors
View Study & Checklist ➔Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
📍 University of California Irvine - Chao Family Comprehensive Cancer Center — Orange, California
Rectal Cancer
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
📍 Mitchell Cancer Institute — Mobile, Alabama
CRC (Colorectal Cancer)
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
📍 Local Institution - 0428 — Tucson, Arizona
Untreated, Unresectable, or Metastatic Colorectal Cancer
View Study & Checklist ➔Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
📍 Centre Hospitalier de l'Université de Montréal (CHUM) — Montreal, Quebec
Metastatic Colorectal Cancer
View Study & Checklist ➔Folfox+Irinotecan+Chemort In Esophageal Cancer
📍 Massachusetts General Hospital — Boston, Massachusetts
Gastroesophageal Junction Adenocarcinoma
View Study & Checklist ➔Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
📍 GSK Investigational Site — Tucson, Arizona
Colonic Neoplasms
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
Metastatic Colorectal Cancer
View Study & Checklist ➔Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
📍 Banner Health- MD Anderson Cancer Center — Gilbert, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
📍 Providence Portland Cancer Institute - Franz Clinic — Portland, Oregon
Advanced Solid Tumors
View Study & Checklist ➔Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Phase 1
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
📍 Local Institution - 0284 — Phoenix, Arizona
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
View Study & Checklist ➔Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Solid Tumor, Adult
View Study & Checklist ➔